MID-VOLUME · HOSP-HEAVY
moxifloxacin Side Effects
moxifloxacin (also sold as Avelox) sits MID-VOLUME #283 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 35.6% mention hospitalization (4,770 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 13,400
- FAERS reports
FDA Adverse Event Reporting System extract for moxifloxacin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
moxifloxacin: 35.6% mention hospitalization (4,770 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #283 of 524 by FAERS report count.
Mid-book FAERS page for moxifloxacin (Avelox) (13,400 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DYSPNOEA leads 1,225 of 13,400 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (3,168 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,914 reports, 14.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 345 |
| DYSPNOEA | 259 |
| PYREXIA | 206 |
| HYPERSENSITIVITY | 204 |
| LUNG DISORDER | 201 |
| FATIGUE | 188 |
| CONDITION AGGRAVATED | 185 |
| ASTHENIA | 179 |
| ANXIETY | 173 |
| PNEUMONIA | 172 |
| ASTHMA | 170 |
| CONFUSIONAL STATE | 170 |
| VOMITING | 170 |
| DIARRHOEA | 167 |
| MALAISE | 165 |
| JOINT SWELLING | 163 |
| STOMATITIS | 163 |
| HEADACHE | 161 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,770, 35.6% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 632 |
| PNEUMONIA | 496 |
| CONDITION AGGRAVATED | 466 |
| PYREXIA | 397 |
| WHEEZING | 394 |
| NAUSEA | 391 |
| VOMITING | 389 |
| ASTHMA | 380 |
| DIARRHOEA | 360 |
| FATIGUE | 349 |
| ANXIETY | 330 |
| HYPERSENSITIVITY | 320 |
| PAIN | 313 |
| LUNG DISORDER | 306 |
| MALAISE | 305 |
| HEADACHE | 304 |
| RASH | 303 |
| ARTHRALGIA | 287 |
How to read moxifloxacin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 13,400 voluntary reports linked to moxifloxacin (Avelox), 2004-2025. Death is listed on 1,914 (14.3%). Hospitalization appears on 4,770 (35.6%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 35.6% mention hospitalization (4,770 reports).
Read with moxifloxacin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 13,367 FAERS cases (Δ 33 lighter vs moxifloxacin); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,451 FAERS cases (Δ 51 heavier vs moxifloxacin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,500 FAERS cases (Δ 100 heavier vs moxifloxacin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,667 FAERS cases (Δ 267 heavier vs moxifloxacin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 47.8 pp vs moxifloxacin's DEATH-HEAVY): CASELOAD · HOSP-MID.
moxifloxacin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.